Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2025-12-31 @ 3:53 AM
Study NCT ID:
NCT04048135
Status:
COMPLETED
Last Update Posted:
2024-04-02
First Post:
2019-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH
Sponsor:
89bio, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-19
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-04
First Submit QC Date:
None
Study First Post Date:
2019-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-03-04
Results First Submit QC Date:
None
Results First Post Date:
2024-04-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-04
Last Update Post Date:
2024-04-02
Last Update Post Date Type:
ACTUAL